Search

everythinglearnresearchcommunity

for

Search:↓

Steroidogenic isoenzymes may help improve treatments for common hair loss.

Hirsute women have lower type 2 17β-HSD enzyme levels, which improve with treatment.

Lack or blocking of SRD5a, a key component in hormone creation, can lead to conditions like pseudohermaphrodism and affect hair growth, bone mass, muscle strength, and reproductive health. More research is needed on its regulation from fertilization to adulthood.

Treating hirsutism in women often requires a mix of medications and cosmetic methods for best results.

Effective treatments for spinal and bulbar muscular atrophy are not yet available; more research is needed.

Hirsutism in women is often due to hormone sensitivity and has significant psychological effects.

Finasteride negatively affects fish reproduction and gonadal development.

Different drugs can treat high male hormone levels in women, but they have various effects and some may harm a fetus.

The document says that hair loss in women is often due to androgenic alopecia, similar to male baldness, and that hirsutism is treated with hormonal and cosmetic methods.

5α-reductase inhibitors don't stop bladder cancer from developing or getting worse.

Testosterone can both promote hair growth and cause baldness by affecting hair growth signals.

Androgens play a key role in hair growth and disorders like baldness and excessive hairiness.

Hormones significantly affect women's sexual function, and more research is needed to improve treatments for sexual dysfunction with minimal side effects.

Hormonal changes and psychological issues can cause sexual dysfunction in postmenopausal women. Behavioral therapy is recommended first, with hormone replacement helping some symptoms but not libido. Testosterone can improve libido, but its effects on overall sexual function are unclear. Emotional and relationship issues should be addressed before using medication, and the benefits and risks of testosterone supplementation should be considered.

Hormonal therapies are effective for managing hair and skin symptoms in women with PCOS.

Hirsutism is often caused by high male hormone levels and can be treated with lifestyle changes and medications.

Spironolactone with an oral contraceptive improved hair growth in women with hirsutism.

These drugs cause hair growth without affecting testosterone or adrenal hormones.

Hair loss in women can be slowed with treatment, but more research needed for better solutions.

DHEA acts like a male hormone on rat skin glands and doesn't turn into female hormones there.

A postmenopausal woman's excessive hair growth and hair loss were due to a non-cancerous ovarian condition, treated successfully with surgery.

Antiandrogens are effective for conditions like prostate cancer and skin issues, but more research is needed to confirm their benefits and minimize side effects.

Rat skin takes up and processes testosterone differently than other organs, with testosterone being more important for the skin than its metabolite 5α-DHT.

Bisphenol-A (BPA) increases connections between brain cells and boosts their activity, but it blocks the effects of a male hormone on brain cell plasticity.

Testosterone may worsen hair loss by affecting hair growth signals, while different prostaglandins can either hinder or promote hair growth.

The document concludes that careful evaluation is key to diagnose and treat women with hair loss, with tests for thyroid, iron, and hormones as needed.

Male hormones affect oil-producing skin cells differently based on their body location, and the drug spironolactone can reduce these effects.

New treatments for PCOS focus on insulin resistance and reducing testosterone levels, along with traditional hormone therapies.

New hair loss treatments may include topical medications, injections, and improved transplant methods.

Women with a certain type of tumor had higher levels of pregnancy hormone and male hormones, which decreased after treatment.